These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9210634)

  • 1. Evidence in favour of high infection rate with hepatitis E virus among young children in India.
    Aggarwal R; Shahi H; Naik S; Yachha SK; Naik SR
    J Hepatol; 1997 Jun; 26(6):1425-6. PubMed ID: 9210634
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the prevalence of IgG antibodies to hepatitis E virus and hepatitis A virus in members of households in the Mekong delta region of Vietnam.
    Kolaitis N
    Am J Trop Med Hyg; 2000 Jan; 62(1):1. PubMed ID: 10761716
    [No Abstract]   [Full Text] [Related]  

  • 3. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.
    Arankalle VA; Tsarev SA; Chadha MS; Alling DW; Emerson SU; Banerjee K; Purcell RH
    J Infect Dis; 1995 Feb; 171(2):447-50. PubMed ID: 7844387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-wise exposure rates to hepatitis e virus in a southern Indian patient population without liver disease.
    Daniel HD; Warier A; Abraham P; Sridharan G
    Am J Trop Med Hyg; 2004 Nov; 71(5):675-8. PubMed ID: 15569803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of IgG antibodies to hepatitis E in urban and rural southern India.
    Vivek R; Chandy GM; Brown DW; Kang G
    Trans R Soc Trop Med Hyg; 2010 Apr; 104(4):307-8. PubMed ID: 19729178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E virus infection in eastern India.
    Bansal J; He J; Yarbough PO; Sen S; Constantine NT; Sen D
    Am J Trop Med Hyg; 1998 Aug; 59(2):258-60. PubMed ID: 9715942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A sero-epidemiological study of hepatitis E among general population in Shandong Province of China in 2014].
    Yan BY; Zhang L; Lyu JJ; Feng Y; Liu JY; Wu WL; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):587-592. PubMed ID: 28693081
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland.
    Bura M; Łagiedo M; Michalak M; Sikora J; Mozer-Lisewska I
    Int J Infect Dis; 2017 Aug; 61():20-22. PubMed ID: 28576599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of antibodies against hepatitis E virus in haemodialysis patients in India.
    Agarwal SK; Irshad M; Dash SC
    Nephron; 1999; 81(4):448. PubMed ID: 10095186
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroprevalence of antibodies to hepatitis E virus in two large communities in Havana, Cuba.
    Villalba MC; Guan M; Pérez A; Corredor MB; Frometa SS; Moreno AG; Hu WP; Howard T; Lay LA; Anderson D
    Trans R Soc Trop Med Hyg; 2010 Dec; 104(12):772-6. PubMed ID: 20870260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan.
    Tanaka E; Matsumoto A; Takeda N; Li TC; Umemura T; Yoshizawa K; Miyakawa Y; Miyamura T; Kiyosawa K
    J Viral Hepat; 2005 Jul; 12(4):439-42. PubMed ID: 15985017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands.
    van Gerven NM; van der Eijk AA; Pas SD; Zaaijer HL; de Boer YS; Witte BI; van Nieuwkerk CM; Mulder CJ; Bouma G; de Man RA;
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):9-13. PubMed ID: 27014749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis E virus in residents of a district in Havana, Cuba.
    Quintana A; Sanchez L; Larralde O; Anderson D
    J Med Virol; 2005 May; 76(1):69-70. PubMed ID: 15779049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic acute hepatitis caused by hepatitis E virus in Egyptian adults.
    Gomatos PJ; Monier MK; Arthur RR; Rodier GR; el-Zimaity D; Hassan NF; Quinti I; el-Sahly AD; Sultan Y; Hyams KC
    Clin Infect Dis; 1996 Jul; 23(1):195-6. PubMed ID: 8816162
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis E virus: Western Cape, South Africa.
    Madden RG; Wallace S; Sonderup M; Korsman S; Chivese T; Gavine B; Edem A; Govender R; English N; Kaiyamo C; Lutchman O; van der Eijk AA; Pas SD; Webb GW; Palmer J; Goddard E; Wasserman S; Dalton HR; Spearman CW
    World J Gastroenterol; 2016 Nov; 22(44):9853-9859. PubMed ID: 27956810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence and risk factors of hepatitis E virus infection among children in China.
    Meng QF; You HL; Wang WL; Zhou N; Dong W; Cong W
    J Med Virol; 2015 Sep; 87(9):1573-7. PubMed ID: 25940435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A community prevalence study of antibodies to hepatitis A and E in inner-city London.
    Bernal W; Smith HM; Williams R
    J Med Virol; 1996 Jul; 49(3):230-4. PubMed ID: 8818970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis E virus antibodies among different groups in the Amazonian basin.
    Kiesslich D; Rocha júnior JE; Crispim MA
    Trans R Soc Trop Med Hyg; 2002; 96(2):215. PubMed ID: 12055819
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran.
    Ramezani A; Velayati AA; Khorami-Sarvestani S; Eslamifar A; Mohraz M; Banifazl M; Bidari-Zerehpoosh F; Yaghmaei F; McFarland W; Foroughi M; Keyvani H; Mostafavi E; Aghakhani A
    Int J STD AIDS; 2013 Oct; 24(10):769-74. PubMed ID: 23970597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis E virus seroepidemiology and its change during 1 year in primary school students in Ankara, Turkey.
    Maral I; Budakoglu II; Ceyhan MN; Atak A; Bumin MA
    Clin Microbiol Infect; 2010 Jul; 16(7):831-5. PubMed ID: 19778297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.